JAAD online
Collodion-like membrane in a newborn exposed to infliximab

https://doi.org/10.1016/j.jaad.2014.01.856Get rights and content
Under a Creative Commons license
open access

Cited by (0)

Funding sources: None.

Disclosure: Dr Brodell is on the speakers bureau for Allergan, Galderma, PharmaDerm (a division of Fougera Pharmaceuticals Inc), and Veregen; a consultant/investigator/advisory board member for Galderma Laboratories LP; and has performed multicenter clinical trials for Genentech and Janssen Biotech Inc. Ms Offiah and Drs Campbell and Wyatt have no conflicts of interest.